Wilson Sonsini Goodrich & Rosati has advised Lexeo Therapeutics, and Paul Hastings has advised the underwriters. Lexeo Therapeutics, a clinical-stage genetic medicine company focused on pioneering...
Lexeo Therapeutics Completes $153.8 Million Public Offering and Private Placement
Ascentage Pharma’s $126.4 Million Initial Public Offering and Nasdaq Listing
Wilson Sonsini Goodrich & Rosati acted as U.S. and Hong Kong counsel to Ascentage Pharma on the offering, and Davis Polk & Wardwell advised the underwriters....
Nuveen Investment’s $20 Million Investment in OnepakNuveen Investment’s $20 Million Investment in Onepak
Wilson Sonsini Goodrich & Rosati advised Onepak on the transaction. Onepak Inc., a digital supply chain and reverse logistics platform that facilitates the flow of used...



























